By Tom Salemi
For years, venture capitalists investing in the medical device and biopharmaceutical fields have found ways to thrive even with the...
For over three decades, medical device investors have accepted the Food and Drug Administration's crucial role as traffic cop for their start-ups. Yes, the agency could be tough, but a green light opened a lucrative road for device companies. But venture capitalists are increasingly worried that tighter controls on regulation could endanger innovation.
By Tom Salemi
For years, venture capitalists investing in the medical device and biopharmaceutical fields have found ways to thrive even with the...